Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Mills

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
The American Journal of Surgical Pathology|May 8, 2013
A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissueAnne M Mills, Frances P Guo, Andrew P Copland, et al.
Case Reports in Obstetrics and Gynecology|February 27, 2026
Incidental Intraplacental Choriocarcinoma in the Setting of Intrauterine Fetal DemiseDavid K Carlson, Gabrielle K Smith, Robin D LeGallo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibitionLisa A Friedman, Timothy N Bullock, Emily A Sloan, et al.
The American Journal of Surgical Pathology|April 23, 2024
Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac MarkersAnne M Mills, Taylor M Jenkins, Megan E Dibbern, et al.
The American Journal of Surgical Pathology|June 5, 2023
Interobserver Agreement on the Interpretation of Programmed Death-ligand 1 (PD-L1) Combined Positive Score (CPS) Among Gynecologic PathologistsAnne M Mills, Jennifer A Bennett, Natalie Banet, et al.
The American Journal of Surgical Pathology|February 23, 2022
Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive EntityAnne M Mills, Taylor M Jenkins, Brooke E Howitt, et al.
Transfusion|March 15, 2012
How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis productsMagali J Fontaine, Anne M Mills, Susan Weiss, et al.
Head and Neck Pathology|May 29, 2016
Sclerosing Microcystic Adenocarcinoma of the Head and Neck Mucosa: A Neoplasm Closely Resembling Microcystic Adnexal CarcinomaAnne M Mills, Maria Luisa C Policarpio-Nicholas, Abbas Agaimy, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2026
MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer PatientsJoseph L Maniaci, Hijun Ryu, Anne M Mills, et al.
The American Journal of Surgical Pathology|September 18, 2014
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancerAnne M Mills, Sofia Liou, James M Ford, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
The American Journal of Surgical Pathology|May 8, 2013
A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissueAnne M Mills, Frances P Guo, Andrew P Copland, et al.
Case Reports in Obstetrics and Gynecology|February 27, 2026
Incidental Intraplacental Choriocarcinoma in the Setting of Intrauterine Fetal DemiseDavid K Carlson, Gabrielle K Smith, Robin D LeGallo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibitionLisa A Friedman, Timothy N Bullock, Emily A Sloan, et al.
The American Journal of Surgical Pathology|April 23, 2024
Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac MarkersAnne M Mills, Taylor M Jenkins, Megan E Dibbern, et al.
The American Journal of Surgical Pathology|June 5, 2023
Interobserver Agreement on the Interpretation of Programmed Death-ligand 1 (PD-L1) Combined Positive Score (CPS) Among Gynecologic PathologistsAnne M Mills, Jennifer A Bennett, Natalie Banet, et al.
The American Journal of Surgical Pathology|February 23, 2022
Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive EntityAnne M Mills, Taylor M Jenkins, Brooke E Howitt, et al.
Transfusion|March 15, 2012
How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis productsMagali J Fontaine, Anne M Mills, Susan Weiss, et al.
Head and Neck Pathology|May 29, 2016
Sclerosing Microcystic Adenocarcinoma of the Head and Neck Mucosa: A Neoplasm Closely Resembling Microcystic Adnexal CarcinomaAnne M Mills, Maria Luisa C Policarpio-Nicholas, Abbas Agaimy, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2026
MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer PatientsJoseph L Maniaci, Hijun Ryu, Anne M Mills, et al.
The American Journal of Surgical Pathology|September 18, 2014
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancerAnne M Mills, Sofia Liou, James M Ford, et al.
Pageof 11